Dietary Approaches to Treating Multiple Sclerosis Related Fatigue
Once you're logged in, please select the "REGISTER" tab to process your payment and complete your registration.
Once you register for the course, you will have 180 days (approximately 6 months) from the date of enrollment to complete the course. The exact date that your access expires will be indicated within the Course Summary box on this webpage.
- Review the published research on dietary interventions for Multiple Sclerosis (MS).
- Identify the mechanisms by which dietary factors may contribute to the potential worsening or improving of MS related symptoms.
- Review the rationale for the structure of the dietary intervention in the Dietary Approaches to Treating MS Related Fatigue Trial NCT02914964.
Terry L. Wahls, MD
Dr. Wahls is a clinical professor of medicine at the University of Iowa where she conducts clinical trials that test the effect of nutrition and lifestyle interventions to treat MS and other progressive health problems. She is also a patient with secondary progressive multiple sclerosis, which confined her to a tilt-recline wheelchair for four years. Dr. Wahls restored her health using a diet and lifestyle program she designed specifically for her brain and now pedals her bike to work each day. Full biography.
Relevant to the content of this CME activity, Dr. Wahls indicates she has the following financial relationships to disclose:
- Grant Funding
- National MS Society
- Trademarks – Wahls™ Diet Plans, Wahls Protocol®
- Financial relationships with Penguin Random House Inc.; Integrative Medicine for Mental Health; Institute for Health and Healing; Suttler Pacific, BioCeuticals; NCURA; MCG Health Inc.; Genova Diagnostics
- Author ‐ Minding My Mitochondria, The Wahls Protocol, The Wahls Protocol Cooking for Life
- Equity interest
- Dr. Terry Wahls LLC
- The Wahls Institute PLC
Copyright: All rights reserved. By viewing this activity, participants agree to abide by copyright and trademark laws, intellectual property rights, and all other applicable laws of the United States of America. No part of the syllabus may be used or reproduced in any manner whatsoever without written permission, except in the case of brief quotations embodied in articles or reviews.
Internet CME Policy: The Office of Continuing Medical Education (CME) at Des Moines University (DMU) is committed to protecting the privacy of its customers. DMU CME maintains its Internet site as an information resource and service for health professionals. DMU CME will keep your personal and credit information confidential when you participate in an Internet based program. Your information will never be given to anyone outside of the DMU CME program. DMU CME collects only the information necessary to provide you with the services that you request.
Continuing Education Credit
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University (DMU) is accredited by IMS to provide continuing medical education for physicians. DMU designates this enduring materials activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 0.75 AOA Category 2-B credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Other Health Professionals: This enduring materials activity is designated for a maximum of 0.75 AMA PRA Category 1 Credit(s)™.
No commercial interest company provided financial support for this continuing education activity.
Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with any commercial interest. They will also disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. Firms providing financial support did not have input in these areas. The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
- 0.75 AOA Category 2B
- 0.75 AMA PRA Category 1 Credits™
- 0.75 CE Contact Hour(s)